Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Shares Outstanding (2016 - 2025)

Lipocine (LPCN) has disclosed Shares Outstanding for 12 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 1.35% year-over-year to $5.4 million, compared with a TTM value of $5.4 million through Sep 2025, up 1.35%, and an annual FY2024 reading of $5.3 million, up 0.6% over the prior year.
  • Shares Outstanding was $5.4 million for Q3 2025 at Lipocine, up from $5.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $88.3 million in Q2 2021 and bottomed at $336.0 in Q2 2022.
  • Average Shares Outstanding over 5 years is $12.9 million, with a median of $5.3 million recorded in 2023.
  • Peak annual rise in Shares Outstanding hit 1581992.26% in 2023, while the deepest fall reached 100.0% in 2023.
  • Year by year, Shares Outstanding stood at $336.0 in 2021, then surged by 1557885.12% to $5.2 million in 2022, then rose by 1.55% to $5.3 million in 2023, then increased by 0.6% to $5.3 million in 2024, then increased by 1.35% to $5.4 million in 2025.
  • Business Quant data shows Shares Outstanding for LPCN at $5.4 million in Q3 2025, $5.4 million in Q2 2025, and $5.4 million in Q1 2025.